Skip to main content
. 2021 Jun 9;13:4597–4604. doi: 10.2147/CMAR.S316470

Table 2.

BRCA1/2 Pathogenic Mutation Rates by Subgroups

Characteristics Number of Patients BRCA1/BRCA2 n (%) P-value
Age at diagnosis (years) <40 85 28 (32.9%) 0.034
≥40 112 22 (19.6%)
Diagnosed at any age with two or more diagnoses of breast cancer at any age (synchronously or asynchronously) Yes 29 12 (41.4) 0.032
No 168 38 (22.6)
Diagnosed at age 50 years or younger with: 1 or more close relatives with breast cancer at any age, 1 or more close relatives with pancreatic cancer, or 1 or more close relatives with prostate cancer (Gleason score ≥7) Yes 74 28 (37.8) 0.002
No 123 22 (17.9)
Diagnosed at any age with 1 or more close relatives with breast cancer diagnosed at age 50 years or younger Yes 47 19 (40.4) 0.007
No 150 31 (20.7)
Nationality Jordanian 170 41 (24.1) 0.307
Others 27 9 (33.3)